Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4636803016 | Alfuzosin hydrochloride 10 mg and dutasteride 500 microgram prolonged-release oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4636804010 | Product containing precisely alfuzosin hydrochloride 10 milligram and dutasteride 500 microgram/1 each prolonged-release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5300371000052111 | alfuzosinhydroklorid 10 mg och dutasterid 500 mikrog, depåtablett | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Alfuzosin hydrochloride 10 mg and dutasteride 500 microgram prolonged-release oral tablet | Is a | Alfuzosin and dutasteride only product in oral dose form | true | Inferred relationship | Some | ||
Alfuzosin hydrochloride 10 mg and dutasteride 500 microgram prolonged-release oral tablet | Has manufactured dose form | Prolonged-release oral tablet | true | Inferred relationship | Some | ||
Alfuzosin hydrochloride 10 mg and dutasteride 500 microgram prolonged-release oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Alfuzosin hydrochloride 10 mg and dutasteride 500 microgram prolonged-release oral tablet | Has precise active ingredient | Dutasteride (substance) | true | Inferred relationship | Some | 1 | |
Alfuzosin hydrochloride 10 mg and dutasteride 500 microgram prolonged-release oral tablet | Has basis of strength substance (attribute) | Dutasteride (substance) | true | Inferred relationship | Some | 1 | |
Alfuzosin hydrochloride 10 mg and dutasteride 500 microgram prolonged-release oral tablet | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
Alfuzosin hydrochloride 10 mg and dutasteride 500 microgram prolonged-release oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Alfuzosin hydrochloride 10 mg and dutasteride 500 microgram prolonged-release oral tablet | Has precise active ingredient | Alfuzosin hydrochloride (substance) | true | Inferred relationship | Some | 2 | |
Alfuzosin hydrochloride 10 mg and dutasteride 500 microgram prolonged-release oral tablet | Has basis of strength substance (attribute) | Alfuzosin hydrochloride (substance) | true | Inferred relationship | Some | 2 | |
Alfuzosin hydrochloride 10 mg and dutasteride 500 microgram prolonged-release oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Alfuzosin hydrochloride 10 mg and dutasteride 500 microgram prolonged-release oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets